16:38 EST Xoma files $200M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on XOMA:
- XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
- Is XOMA a Buy, Before Earnings?
- XOMA to Present at Upcoming Investor Conferences in March
- Kinnate Biopharma price target raised to $2.59 from $1.50 at Stifel
- Xoma acquisition boosts royalty growth potential, says H.C. Wainwright